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Abstract: The class of Cullin–RING E3 ligases (CRLs) selectively ubiquitinate a large portion of 
proteins targeted for proteolysis by the 26S proteasome. Before degradation, ubiquitin molecules 
are removed from their conjugated proteins by deubiquitinating enzymes, a handful of which are 
associated with the proteasome. The CRL activity is triggered by modification of the Cullin subunit 
with the ubiquitin-like protein, NEDD8 (also known as Rub1 in Saccharomyces cerevisiae). Cullin 
modification is then reversed by hydrolytic action of the COP9 signalosome (CSN). As the NEDD8–
Rub1 catalytic cycle is not essential for the viability of S. cerevisiae, this organism is a useful model 
system to study the alteration of Rub1–CRL conjugation patterns. In this study, we describe two 
distinct mutants of Rpn11, a proteasome-associated deubiquitinating enzyme, both of which exhibit 
a biochemical phenotype characterized by high accumulation of Rub1-modified Cdc53–Cullin1 
(yCul1) upon entry into quiescence in S. cerevisiae. Further characterization revealed proteasome 
19S-lid-associated deubiquitination activity that authorizes the hydrolysis of Rub1 from yCul1 by 
the CSN complex. Thus, our results suggest a negative feedback mechanism via proteasome 
capacity on upstream ubiquitinating enzymes. 
Keywords: 26S proteasome; proteasome lid; Rpn11; Cdc53; Cullin; SCF (Skp, Cullin, F-box 
containing complex); NEDD8 (neural precursor cell expressed developmentally down-regulated 8); 




One of the major mechanisms to regulate proteostasis in cells is the posttranslational 
modifications of proteins by polypeptide modifiers, such as ubiquitin (Ub), and family members 
known as ubiquitin-like (Ubl) proteins [1]. Modification of proteins by Ubls is a process involved in 
various cellular responses, the most famous of which is protein modification by Ub and its 
comprehensive role in the Ub proteasome system (UPS) [2]. Ubiquitination is an ATP-consuming 
process that occurs through covalent attachment between a specific Lys residue in target proteins and 
Gly–Gly residues at the carboxyl terminus of Ub [3]. Ubiquitination requires a cascade of enzymes, 
which activate (E1), conjugate (E2), and eventually ligate (E3) ubiquitin to target proteins, resulting 
primarily in their proteasomal degradation [3,4]. Substrate selectivity of Ub attachment is determined 
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by E3 ligases; each of them binds to specific substrate(s) and catalyzes their covalent attachment to 
Ub chains [5]. The modular family of Cullin-RING Ub ligases (CRLs) constitute the largest class of E3 
ligases [6,7], represented by the archetypical Skp, Cullin, F-box containing complex (SCF) [5,8]. The 
SCF includes a Cdc53–Cullin1 (herein yCul1) scaffold subunit that interacts with the RING E3 
subunit, Rbx1, via its carboxyl terminus and with the Cullin-specific adaptor protein (Skp1) via its 
amino terminus. Skp1 binds an F-box protein (Fbp) that serves as a substrate receptor, providing 
specificity to the enzymatic complex by selecting substrates for ubiquitination [5,8]. Cdc4 is an 
essential and highly characterized Fbp in S. cerevisiae. Cdc4 recognizes Sic1 for ubiquitination, leading 
to its proteasomal degradation [9]. Sic1 is an inhibitor of cyclin-dependent kinase (CDK)–cyclin B 
activity, and its degradation promotes DNA replication [9,10]. Sic1 is phosphorylated in the late G1 
phase by G1-cyclin CDK (Cln-Cdc28) activity, which results in Cdc4 recognizing it [11]. Sic1 
phosphorylation is antagonized by the cell cycle phosphatase, Cdc14, which leads to its stabilization, 
accumulation, and consequently to cell cycle arrest. Additional substrates of Cdc4 include the Cln–
Cdc28 inhibitor Far1, the replication protein Cdc6, and the transcription factor Gcn4 [12]. Notably, 
Fbps are short-lived proteins that are switched off by autoubiquitination within their own SCF 
complex [13]. With dozens of Fbps identified in the human genome and hundreds of potential 
substrate adaptors to other Cullins, CRLs form hundreds of assemblages, modifying thousands of 
proteins by Ub, accounting for approximately one-fifth of all proteasome substrates [14,15]. 
CRLs are activated upon covalent modification of their Cullin subunit by NEDD8 (also known 
as Rub1 in S. cerevisiae and plants), the closest paralog of Ub. NEDD8–Rub1 is required for vitality in 
all studied organisms, with the notable exception of S. cerevisiae [16]. S. cerevisiae Rub1 is activated by 
a particular heterodimeric E1 enzymatic complex Ula1–Uba3, and transferred to its cognate E2 
enzyme, Ubc12 [17]. In the next step, Ubc12–Rub1 interacts with Rbx1, triggering the transfer of Rub1 
to a specific Lys residue on the Cullin [18]. Cullins undergo cycles of Rub1 conjugation and 
deconjugation (also known as NEDDylation and deNEDDylation) during their catalytic cycle. The 
deNEDDylation of Rub1 from Cullins is performed by the COP9 signalosome (CSN), an 
evolutionarily conserved multi-subunit complex [19]. In addition to deNEDDylation activity, the 
CSN also hinders both substrate recognition and ubiquitination by CRLs [20-24]. Although neither 
CSN nor Rub1 are strictly essential in budding yeast, CSN does drive canonical Cullin 
deNEDDylation in this model organism as well. However, its mechanistic purpose remains unclear 
[25-28]. With only six subunits, S. cerevisiae harbors the smallest and most diverged CSN complex, 
four of which contain a proteasome, CSN, and eIF3 (PCI) homology domain [29], one catalytic MPN+ 
subunit, Csn5–Rri1, and an endemic subunit harboring the S6CD domain [26,30-32]. As in all other 
model organisms, mutants in any S. cerevisiae CSN subunit share a characteristic biochemical 
phenotype of accumulated yCul1R [19,26,30]. An interesting characteristic of CSN is the close 
homology to the 19S-lid, the distal part of the regulatory particle (RP) of the 26S proteasome [29,33], 
so much so that one of the subunits of S. cerevisiae, Rpn5, was identified as a bona fide subunit of both 
complexes [30-32]. Both, the CSN and the 19S-lid belong to the PCI family of complexes. Six subunits 
of canonical complexes bear the hallmark PCI domain alongside two subunits carrying an Mpr1–
PAD1–N-terminal (MPN) domain [34]. In each complex, one of the MPN subunits is a catalytically 
active MPN+–JAMM (JAB1/MPN/Mov34 metalloenzyme) metalloprotease, namely Csn5 in CSN 
[25,35] and Rpn11 in 19S-lid [36-38]. In accordance, the substrates of these two enzymes are also close 
paralogues—Cullin–Rub1 for Csn5, and Ub conjugates for Rpn11 [39]. Single-site mutations in 
MPN+–JAMM residues of either Csn5 or Rpn11 cause a decrease in CSN deNEDDylation and 
proteasome deubiquitination (DUB), respectively [25,36,37]. In this study, we observed that certain 
mutants of Rpn11 in S. cerevisiae are characterized by accumulation of yCul1R during the post-diauxic 
shift state prior to saturation. At this cellular phase, nutrients become limiting and yeast cells stop 
dividing [40]. Further characterization revealed that proteasome 19S-lid-associated DUB activity 
attributed to Rpn11 is essential before the hydrolysis of Rub1 from yCul1R conjugates by the CSN 
complex.  
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2. Materials and Methods 
2.1. Yeast Strains and Growth Conditions 
This study included widely used W303 and BY4741 laboratory strains of S. cerevisiae. The 
experiments obtained a similar pattern of results for both studied strains. Double mutants used in 
this study were generated by mating haploid strains, sporulation, and tetrad dissection. Genotypes 
and mating types of haploid progeny were determined by phenotype, auxotrophic analysis, 
polymerase chain reaction (PCR), and immunoblotting. Unless otherwise specified, S. cerevisiae cells 
were grown in standard growth conditions at a permissive temperature of 28 °C. All yeast strains 
were grown on glucose-rich YPD (yeast extract 1%, peptone 1%, dextrose 2%) medium (or in non-
fermentable glycerol-containing YPG (yeast extract 1%, peptone 1%, galactose 2%) medium. Both 
YPD and YPG were complemented with adenine hemisulfate (0.004%). For all treatments, unless 
stated otherwise, starter cultures were grown overnight, diluted to OD600 = 0.5, and incubated for an 
indicated number of times, temperatures, or treatments, as described in the figure legends. Growth 
phases were determined according to Bramasole et al. 2019 [41] as follows: early logarithmic phase, 
4–6 h; logarithmic phase, 6–8 h; diauxic shift, 10–12 h; post diauxic phase, >22 h. Plasmids were 
maintained by culturing plasmid-containing strains in a selective synthetic complete (SC) medium 
based on yeast nitrogen base (YNB) supplemented with ammonium sulfate, in which a complete 
mixture of amino acids supplements each of the commonly encountered auxothropies. For 
proteasome inhibition, MG132 (dissolved in dimethyl sulfoxide (DMSO)) was added for 2 h to either 
the YPD growth medium of the Δpdr5 mutant strain or to a unique growth medium previously 
described for other strains [42]. Yeast strains and plasmids used in this study are listed in Tables 1 
and 2. 
2.2. Vitality Test 
To evaluate the viability of various single deletion mutants, a drop dilution assay in YPD was 
utilized. Overnight grown cultures in YPD were harvested and washed twice with sterile distilled 
water. Equal numbers of cells (confirmed by cell counting) were used for a ten-fold serial dilution, 
followed by spotting 2 µL of cultures on YPD plates that were then incubated at 28 °C for 24–48 h. 
For the double mutants, two hundred cells of each yeast strain at the logarithmic phase were plated 
in YPD in triplicate. Agar plates were incubated at 28 °C for 2–3 days. Grown colonies were counted. 
Vitality was estimated by calculating the percentage of viable cells out of the total number of cells 
that were initially plated. Each experiment was repeated three times. 
2.3. Cell Harvest and Immunoblotting 
To denature total cell extracts, cells were harvested in trichloroacetic acid (TCA) as previously 
described [30]. Samples were resolved by SDS-PAGE (sodium dodecyl sulfate - polyacrylamide gel) 
and transferred to a nitrocellulose membrane for immunoblotting. Experiments were repeated at 
least three times and a representative result is shown. 
2.4. Calmodulin-Based Affinity Purification 
Yeast cultures were grown overnight in SC medium and transferred for five additional hours at 
34 °C. Cells were pelleted, washed twice with double-distilled water (DDW), and then washed once 
with chilled (4 °C) Calmodulin binding buffer (25 mM Tris [pH 7.4], 200 mM NaCl, 2 mM CaCl2, 0.2% 
NP-40, 5 mM NaF) complemented by β-mercaptoethanol and a cocktail of free-ethylene diamine 
tetra-acetic acid (EDTA) protease inhibitors.. The pellet was re-suspended in two volumes of the same 
buffer and lysed by glass beads at 4 °C. Clarified lysates were incubated with calmodulin sepharose 
beads (GE Healthcare) for 3–16 h at 4 °C and washed with 20 volumes of binding buffer. Bound 
proteins were eluted in elution buffer (the same as the binding buffer, but containing 2 mM ethylene 
glycol tetra-acetic acid (EGTA) instead of the 2 mM CaCl2). Eluted proteins were subjected to 
immunoblotting. 
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2.5. Histidine-Based Affinity Purification 
Yeast cells ectopically expressing RGS–8His–yCul1 were grown in SC medium for 16 hours at a 
permissive temperature of 28 °C. Cells were harvested and the pellet was washed twice with double 
distilled water; 250 OD600 of each strain were dissolved in chilled cell lytic Y cell lysis reagent (Sigma-
Aldrich, St. Louis, Missouri; USA) complemented with EDTA-free protease inhibitor (Thermo Fisher 
Scientific, Waltham, MA USA) and extracted at 4 °C by glass beads. Clarified lysates were mixed in 
a 1:1 ratio with 2 × Ni–NTA binding buffer (50 mM Tris pH 7.4, 300 mM NaCl, 40 mM imidazole). 
For pulldown, Ni–NTA beads were added to 1mg of each lysate and incubated overnight at 4 °C. 
Beads were washed five times with 1 × Ni–NTA binding buffer and elution was performed with the 
same buffer complemented with 250 mM imidazole. Eluted proteins were subjected to 
immunoblotting. 
2.6. Microscopy 
2.6.1. Light Microscope Imaging 
To visualize cell morphology and cell cycle arrest, yeast strains were grown at 28 °C for 16 h and 
shifted to a restrictive temperature of 37 °C for 5 h to enhance cell cycle defects. Samples from the 
growing cells were taken directly to slides and visualized under light microscope with ×400 
magnification. 
2.6.2. Confocal Imaging for Rpn5 
For Rpn5 localization, W303 WT (wild type) and rpn11–m1 with genomic tagged Rpn5–GFP at 
the precise chromosomal location were used. For insoluble protein deposit (IPOD) and juxta nuclear 
quality control compartment (JUNQ) localization, the aforementioned strains were further 
ectopically transformed with plasmids expressing either mCherry–VHL (von Hippel-Lindau) or 
mCherry–Rnq1. For live imaging, strains were incubated overnight at 28 °C in SC Ura medium, and 
later shifted from SC Ura medium containing 2% galactose to an initial 0.2 OD600 at 28 °C or 34 °C for 
5 h. Aliquots of cells were immediately transferred to slides for live cell microscopy at room 
temperature under a confocal laser scanning microscope (Carl Zeiss, LSM 710, Oberkochen, 
Germany). Images were captured at ×63 objectives with a zoom of ×6.5; 0.5 µm interval Z-stack images 
were used for three-dimensional (3D) reconstruction using Canvas 10 software. 
2.6.3. Florescent Imaging 
Cells were grown in YPD supplemented with adenine at 34 °C for 5 h. Aliquots of cells were 
immediately fixed and 4',6-diamidino-2-phenylindole (DAPI) was added until a final concentration 
of 2.5 µg/mL was reached. Cells were visualized with fluorescence microscopy. The fluorescence was 
observed with filter sets (365 nm excitation and 445/450 nm emission) for DAPI. The microscope used 
was a Zeiss Axio Imager Z1 florescence microscope with an AxioVision 4.8 digital image processing 
system, and the objective lens was ×63 oil LSM 710 (Carl Zeiss). 
2.7. Antibodies 
The following antibodies were used: anti-Cdc53 (yCul1), anti-Sic1, anti-Cdc4, anti-Actin, and 
anti-CBP (Dako, Santa Cruz, CA, USA); anti-Ub (Dako); anti-Rpn11 and anti-Rpn12 [30]; anti-Rpn8 
[43]; and anti-Rpn1 and anti-Rpn2 [44]. 
2.8. Inhibition of COP9 signalosome (CSN) Activity 
The CSN5i-3 inhibitor [45] was provided by Novartis (Novartis Institutes for BioMedical 
Research, Basel, Switzerland) for Medical Research under the terms of the Novartis Transfer 
Agreement for academic research proposes. Cultures were grown overnight and diluted in YPD to 
0.5 OD600 and grown for 6 h before the addition of CSN5i-3 from a 20 mM stock diluted in DMSO. 
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Cullin NEDDylation status was assessed by immunoblotting. The ratio of yCul1R to yCul1 in CSN5i-
3-treated and untreated cells was quantified by IMAGEJ v1.40f software (http://imagej.net/). The 
inhibition was calculated as a ratio of the accumulated yCul1R in treated and untreated cells. The 
average of three independent experiments was calculated, including standard deviation.  
Table 1. Plasmids used in this study. 
 Name Description Source 
EP25 Csn5-TAP GAL1p [CSN5-TAP] Open Biosystems 
EP53 empty vector Yeplac181  
EP134 CDC14-GFP GAL1p [CDC14-GFP], Amp [46] 
EP149 empty vector pYes2   
EP150 pYC-RPN8 pADH1, [RPN8], Amp  [47] 
EP228 mch-VHL GAL1p [VHL-mCherry], Amp [48] 
EP229 mch-Rnq1 GAL1p [Rnq1-mCherry], Amp [48] 
EP204 CBP -Rpt6 RPT4p, [CBP-A2-RPT6-LEU2], Amp [30] 
EP234 Rpn5-TAP ADH1p [Rpn5-TAP] Open Biosystems 
EP235 ScRpn5 RPN10p [RPN5], Amp [30] 
M134 RPN11 C116>A YCPlac111, RPN11p [rpn11C116/A], Amp [37] 
M138 RPN11 D116>S YCPlac111, RPN11p [rpn11C116/S], Amp [37] 
M143 RPN11 H111>A YCPlac111, RPN11p [rpn11H111/A], Amp [37] 
M144 RPN11 S119>A YCPlac111, RPN11p [rpn11S119/A], Amp [37] 
M145 RPN11 D122>A YCPlac111, RPN11p [rpn11H122/A], Amp [37] 
Table 2. Saccharomyces cerevisiae strains used in this study. 
Name Strain Genotype Source 
RC1 Δcsn9 W303: csn9:: G418 This study 
RC6 rpn11-m1–Δcsi1 
W303 ade2-1; can1-100; his3-11,15; leu2-3, trp1-1; 
ura3-1; GAL+; lys2, KanMX4::YMR025W This study  
RC13 rpn11-m1–Δcsn9 
W303 ade2-1; can1-100; his3-11, 15; leu2-3, trp1-1; 
ura3-1; GAL+; lys2, KanMX4::YDR079C This study 
RC21 ΔYJR084W W303 YJR084W:: G418 This study 
RC22 rpn11-m1–ΔYJR084W 
W303 ade2-1; can1-100; his3-11,15; leu2-3, trp1-1; 
ura3-1; GAL+; lys2::ΔYJR084W This study 
RC25 Δcsi1 W303: csi1:: G418 This study  
YP61 ∆ubp6 BY4741 lys2-801 leu2-3, 2-112, ura3-52, his3-Δ200, 
trp1-1, Δubp6::HIS3 Open Biosystems 
YP76 ∆ubp15 BY4741 his3Δ1 leu2Δ0 ura3Δ0 met15Δ1, 
UBP::KanMX4 Open Biosystems 
YP77 ∆ubp16 BY4741; his3Δ1 leu2Δ0 ura3Δ0 met15Δ1, 
UBP::KanMX4 Open Biosystems 
YP86 ∆ubp1 BY4741 his3Δ1 leu2Δ0 ura3Δ0 met15Δ1, 
UBP::KanMX 
EUROSCARF (Oberursel,  
Germany) 
YP87 ∆ubp2 BY4741 his3D1; leu2D0; met15D0; ura3D0; 
YOR124c::kanMX4 
EUROSCARF (Oberursel,  
Germany) 
YP89 ∆ubp5 BY4741 his3Δ1 leu2Δ0 ura3Δ0 met15Δ1, 
UBP::KanMX4 Open Biosystems 
YP90 ∆ubp7 BY4741 his3Δ1 leu2Δ0 ura3Δ0 met15Δ1, 
UBP::KanMX4 Open Biosystems 
YP91 ∆ubp8 BY4741 his3Δ1 leu2Δ0 ura3Δ0 met15Δ1, 
UBP::KanMX4 Open Biosystems 
YP92 ∆ubp9 BY4741 his3Δ1 leu2Δ0 ura3Δ0 met15Δ1, 
UBP::KanMX4 Open Biosystems 
YP94 ∆ubp11 BY4741 his3Δ1 leu2Δ0 ura3Δ0 met15Δ1, 
UBP::KanMX4 Open Biosystems 
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YP207 Δcsn11 W303: csn11:: G418 This study 
YP212 rpn11-m1–Δcsn5 
W303 ade2-1; can1-100; his3-11,15; leu2-3, trp1-1; 
ura3-1; GAL+; lys2, KanMX4::YDL216C This study 
YP216 rpn11-m1–Δcsn11 
W303 ade2-1; can1-100; his3-11,15; leu2-3, trp1-1; 
ura3-1; GAL+; lys2, KanMX4::YIL071C This study 
YP334 W303 
(parental) 
Mat a, his3-200, ade2-101, leu21,ura3-52, lys2-801, 
trp162 
 
YP335 Δcsn5 W303: Csn5:: KanMX4 [49] 
YP336 Δrub1 W303 his3ko1;leu2ko0;met15ko0;ura3ko0  
 YDR139c::kanMX4 This study 





W303 Mat a, his3_-200, ade2-101, leu2_1, ura3-52, 




W303 Mat a, his3_-200, ade2-101, leu2_1, ura3-52, 





W303 MATa leu2-3,112 trp1-1 can1-100 ura3-1 





W303 MATa leu2-3,112 trp1-1 can1-100 ura3-1 
ade2-1 his3-11,15 rpn11-m1:3HA-KANMX6, 
RPN5:GFP(S65T)-TRP1  
[50] 
YP452 cdc14-3 BY4741 his3ko1;leu2ko0;lys2ko0;ura3ko0 [46] 
YP531 cdc4-1 
W303 ura3-1,can1-100, gal+, leu2-3,112. trp1-1; 
ade2-1; his3-11,15; cdc4-1 [51] 
MY321 rpn11D122/A BY4741 his3ko1; leu2ko0; met15ko0; ura3ko0 
YFR004W:kanMX4 with plasmid M145 [37] 
MY317 rpn11C116/A BY4741 his3ko1; leu2ko0; met15ko0; ura3ko0 
YFR004W:kanMX4 with plasmid M134  [37] 
MY318 rpn11C116/S BY4741 his3ko1; leu2ko0; met15ko0; ura3ko0 
YFR004W:kanMX4 with plasmid M138 [37] 
MY319 rpn11H111/A BY4741 his3ko1; leu2ko0; met15ko0; ura3ko0 
YFR004W:kanMX4 with plasmid M143 [37] 
MY320 rpn11S119/A BY4741 his3ko1; leu2ko0; met15ko0; ura3ko0 
YFR004W:kanMX4 with plasmid M144 [37] 
MY1021 Δpdr5 W303 ura3-1; can1-100; GAL+leu3,112,trp1-1; 
ade2-1; his3-11,15; pdr5::hisG [52] 
MY1424 rpn11-m1–Δpdr5 
W303 ura3-1; can1-100; GAL+leu3,112,trp1-1; 
ade2-1; his3-11,15; pdr5::hisG; YFR004W::rpn11-m1 This study 
3. Results and Discussion 
3.1. Distinct rpn11 Mutants Accumulate yCul1R 
Two distinct mutants of Rpn11 were employed in this study: the catalytic dead mutant 
rpn11D122/A, and rpn11-m1, a carboxyl-terminal truncated mutant lacking 31 amino acids, which were 
replaced by nine other amino acids due to a frameshift (mpr1-1) [37,53] (Figure 1A). Both rpn11D122/A 
and rpn11-m1 are temperature-sensitive mutants that share physiological and biochemical 
phenotypes, such as cell cycle defects, accumulation of Ub chains, and defects in proteolysis [37,47]. 
However, rpn11-m1 exhibits additional defects in 26S proteasome integrity by forming an incomplete 
19S-lid subcomplex attached to 19S base-CP [43]; rpn11-m1 also displays mitochondrial phenotypes 
when grown above a semi-restrictive temperatures (>32 °C) [41,54]. 
In a previous study we described a phenotype of rpn11-m1 that exhibits a high ratio of modified 
to unmodified yCul1 at the end of the logarithmic phase in 34 °C, distinguishing this mutant from 
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rpn11D122/A [41] (Figure 1B; 8 h). Further characterization revealed that rpn11-m1 mutant cells lack a 
redox-dependent thiol switch-off of Cullin NEDDylation enzymes because of a failure to shift into 
mitochondrial respiration when glucose in the growth medium is exhausted (diauxic shift) [41] 
(Figure 1B; 8 h). Nevertheless, rpn11-m1 retained elevated levels of yCul1R during the post-diauxic 
phase, a state in which constituent cells proliferate very slowly and readjust their metabolism to 
utilize other carbon sources present in the medium [40]. Supporting the notion that this case was not 
mitochondria-related, yCul1R was also accumulated in the rpn11D122A mutant (Figure 1B; 24 h). High 
yCul1R status was detected in both rpn11 mutants, even at a permissive temperature of 28 °C, at 
which respiration defects of rpn11-m1 were diminished and Ubc12~Rub1 thioester forms vanished 
(Figure 1C,D; Figure S1A,B) [41]. Respectively, high yCul1R were detected when shifting overnight 
cultures to nutrient-rich growth media, including the non-fermentable carbon source glycerol 
(forcing mitochondrial respiration) as a sole energy source (Figure 1C). The high ratio of yCul1R in 
rpn11 mutants correlating with accumulation of the short-lived proteasome substrate, Cdc4, due to 
defects in proteolysis [47,55] (Figure 1C, middle; Figure S1C). The high ratio of yCul1R is also 
observed in various rpn11-metalloprotease deficient MPN+–JAMM point mutants (rpn11H111A, 
rpn11S119A, and rpn11D122A), but not in silent mutations (rpn11C116A and rpn11D116S) (Figure 1A,D; Figure 
S2). Notably, the accumulation of yCul1R differentiates rpn11 mutants from deletion mutants of other 
please define. None of the latter mutants exhibited this biochemical phenotype, neither when glucose 
in the growth medium was exhausted at the post diauxic phase or when the carbon source was 
replaced by glycerol (Figure S3). 
 
Figure 1. Distinct rpn11 mutants exhibit high yCul1 NEDDylation status at the post diauxic phase. 
(A) Schematic representation of WT (wild type) Rpn11 and the distinct mutants of rpn11-m1 and 
rpn11D122/A. WT Rpn11 includes 306 amino acids and bears an MPN domain at the amino terminal 
domain (white) with an MPN+–JAMM motif (black). This motif is mutated in rpn11D122/A, leading to 
defects in metalloprotease activity (dotted square). The mutant of rpn11-m1 is shorter due to a 
frameshift, causing the absence of 31 carboxyl terminal amino acids and their replacement by nine 
other amino acids. (B) WT and mutated Rpn11 (rpn11-m1 and rpn11D122/A) cells at the post-diauxic 
phase were diluted in YPD (yeast extract, peptone, dextrose) to 0.5 OD600 and grown at 34 °C. The 
modification status of yCul1 was examined by immunoblotting at indicated time points. Note: DS—
diauxic shift. (C) WT and rpn11 mutants (rpn11-m1 and rpn11D122/A) at the post-diauxic phase were 
pre-washed and diluted to 0.5OD600 in YPG (yeast extract, peptone, glycerol). The modification status 
of yCul1 was examined by immunoblotting at indicated time points. (D) Overnight-grown WT, Δcsn5, 
and various mutants of Rpn11 with a silent mutation (rpn11C116A, rpn11C116S) or active site dead 
mutation (rpn11S119A, rpn11D122A) were diluted to 0.5OD600 and grown in YPD at 25 °C for 120 h before 
examination of yCul1 modification status by immunoblotting. Notably, a permissive temperature of 
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25 °C was used for the long-term growth (120 h) of the rpn11D122/A mutant to prevent growth defects 
and lethality [37]. 
3.2. The Accumulation of yCul1R in rpn11 Mutants Is Not Associated with Cell Cycle Defects 
The accumulation of yCul1R could be associated with physiological or biochemical phenotypes 
shared between rpn11-m1 and rpn11D122A. However, this phenotype may be an indirect consequence 
of their common cell cycle arrest phenotype [37,47] rather than a direct consequence of Rpn11 
function (as a proteasome-associated DUB). Both rpn11 mutants demonstrated morphology of 
elongated bud and pre-anaphase arrest. Previous studies showed that the overexpression of CDC14, 
a phosphatase of the mitotic exit, suppresses the associated cell cycle phenotypes in rpn11-m1, 
suggesting a positive genetic interaction between these proteins and location of Rpn11 upstream to 
Cdc14 [46]. However, although the overexpression of CDC14 restored defects in cell cycle it did not 
alter the accumulated yCul1R in rpn11-m1 (Figure 2B). In agreement, the cell cycle phenotype 
observed in rpn11 mutants is shared with cdc14-3 mutation of CDC14 (Figure 2A). However, unlike 
rpn11 mutants, the yCul1R to yCul1 ratio between in cdc14-3 is similar to WT (Figure 2C; top). The 
accumulation of yCul1R in rpn11 mutants also correlated with the accumulation of the SCFCdc4 product 
Sic1 (Figure 2B; bottom). Remarkably, Sic1 is moderately accumulated in rpn11D122/A and highly 
accumulated in rpn11-m1. A possible reason for this discrepancy between the studied mutants is the 
essentiality of the carboxyl terminal domain of Rpn11 (missing only in rpn11-m1 but not in rpn11D122/A) 
for the regulation of CDC14 [46], which in turn is responsible for the turnover of Sic1 [56]. The above 
results suggest that the accumulation of yCul1R in rpn11 mutants is not influenced by the cell cycle. 
This assumption is further supported by the finding that overexpression of RPN8 in rpn11-m1 
partially suppresses defects associated with proteasome structure and cell cycle [47], but does not 
lead to alterations in yCul1 modification status (Figure S4). Likewise, NEDDylation status of yCul1 
was not altered even upon synchronization of WT cells in the G1–S-phase boundary by α-factor-
mediated arrest for 150 min followed by release back into the cell cycle (Figure 2D). Altogether, our 
findings suggest that the NEDDylation status of yCul1 is influenced by biochemical properties rather 
than by the cell cycle.  
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Figure 2. Cell cycle does not determine yCul1 NEDDylation status. (A) WT and mutant yeast strains 
were grown at 28 °C for 16 h, then shifted to a restrictive temperature of 37 °C for 5 h to enhance 
cellular phenotypes. (A) Cell cycle defects were observed by light microscope (magnification x400). 
(B) The rpn11-m1 mutant cells were grown overnight in raffinose and diluted to 0.5 OD600 in galactose 
(YP Gal) to induce the expression of CDC14 or a vehicle plasmid, or in glucose (YPD) for control. The 
extent of yCul1 modification by Rub1 was examined by immunoblotting of total protein extracts with 
yCul1 antibody. (C) Yeast strains were grown as previously explained (A), followed by extraction of 
total protein extracts used for yCul1 immunoblotting. The accumulation of the short-lived F-box 
protein Cdc4 and its substrate Sic1 was validated as well. Note that cdc4-1 is a control for decreased 
endogenous levels of the yCul1Cdc4 complex. Cdc4 expression shows a negative correlation with the 
accumulated Sic1. (D) WT cells were grown in glucose supplemented by α factor for 150 min for 
synchronization of the cell cycle in G1. Synchronized cells were washed and were then grown in YPD. 
Samples were taken before and after synchronization at indicated times and subjected to 
immunoblotting with yCul1. The cell cycle stage was analyzed by quantitation of DNA content by 
flow cytometry. 
3.3. Rpn5 Availability Is Sufficient in rpn11-m1 
In S. cerevisiae, Rpn5 plays a dual role serving as both a 19S-lid and as a CSN subunit [30,32]. 
Before quiescent, Rpn5 together with other subunits of the 26S proteasome migrate into cytoplasmic 
structures named proteasome storage granules (PSG) [57]. PSGs protect proteasomes from rapid 
degradation via autophagy or from aggregation [58,59]. Proteasomes of rpn11-m1 cannot migrate to 
PSGs [50]. Considering the non-essentiality of the yeast CSN, the above may lead to a drift of Rpn5 
toward the essential proteasome, hence resulting in CSN malfunction, which could explain the 
accumulation of yCul1R. Indeed, impairment of proteasome lid assembly was shown to be associated 
with aggregation of proteasome subunits in subcellular stress foci as insoluble aggregates known as 
insoluble protein deposit (IPOD) and with aggregation of ubiquitinated unfolded proteins in a site of 
sequestration, known as juxtanuclear quality control (JUNQ) [48,60]. To evaluate the possible 
aggregation of Rpn5, we examined the distribution of a genomic Rpn5-GFP in rpn11-m1 mutant 
strain, transformed independently with a plasmid of either Gal1p-mCherry-VHL (marker for IPOD) 
or Gal1p-mCherry-Rnq1 (marker for JUNQ). Cells were grown to the post-diauxic phase at 28 °C and 
at 34 °C (to induce aggregation), and co-localization was assessed using a confocal microscope (Figure 
3). 
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Figure 3. Intracellular distribution of Rpn5 in rpn11-m1. (A) WT (left) and rpn11-m1 mutant cells 
(right) expressing a genomic copy of Rpn5–GFP and plasmids expressing either mCherry-VHL (top) 
or mCherry-Rnq1 (bottom). Cells were grown at indicated temperatures for 5 h and images of living 
cells were taken by ×100 oil immersion objective using a confocal microscope (Zeiss LSM 510). Z 
stacked images were captured at 0.5 µM intervals and images were processed using Zen Lite software. 
(B) Total cell extracts from rpn11-m1 constitutively expressing Rpn5-TAP under ADH1 promoter or 
expressing Rpn5 under the control of RPN10 promoter were resolved in polyacrylamide gel and 
blotted with anti-yCul1 and anti-Rpn5. 
Consistent with previous studies and in comparison to WT, the localization of Rpn5-GFP in 
rpn11-m1 at 28 °C was primarily nuclear with some cytosolic dispersion [50]. Rpn5-GFP was mostly 
soluble in the mutant, except for a slight co-localization with JUNQ (Figure 3A, bottom). At 34 °C, 
unlike WT, the distribution of Rpn5-GFP in rpn11-m1 was mainly cytosolic [50,61], with minor co-
localization with IPOD and JUNQ (Fig 3A; right). This confirms that Rpn5-GFP in rpn11-m1 is soluble, 
even though it is partially improperly co-localized with the CSN that is predominantly nuclear in 
budding yeast [26]. To examine if high yCul1R status is due to deprivation of Rpn5, yCul1 
NEDDylation status was assessed in rpn11-m1 upon ectopic expression of RPN5 through plasmids 
that suppress CSN structure or function deficiency of rpn5-1 (a carboxyl terminal truncated mutant 
of Rpn5 that cannot integrate into the CSN complex) [30]. However, the overexpression of Rpn5 did 
not alter the yCul1R to yCul1 ratio in rpn11-m1 (Figure 3B). Taken together, rpn11-m1 includes 
sufficient levels of Rpn5, and hence a direct involvement of Rpn11 enzymatic activity in determining 
the yCul1R to yCul1 ratio is proposed.  
3.4. Rpn11-Mediated deubiquitinase Activity Authorizes COP9 signalosome-Mediated deNEDDylation of 
yCul1  
Since cullin deNEDDylation is not an inherent enzymatic property of the proteasome [30], Rpn11 
DUB activity might regulate the hydrolysis of Rub1 from yCul1 by another mechanism. Hydrolysis 
of Ub by intact 19S-lid harboring active Rpn11 is coupled with translocation of substrates into the 19S 
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ATPases ring for unfolding, therefore activity of this DUB is ATP-dependent [2,62]. Previous studies 
suggested a direct interaction between the 19S proteasome and the SCF upon ATP depletion, causing 
the stabilization of classic SCF substrates and suggesting their improper translocation [62]. We 
hypothesized that Rpn11 dysfunction would lead to stabilization of these 19S proteasome–SCF 
interactions. To evaluate this hypothesis, we examined SCF–proteasome interactions in WT and 
rpn11-m1 mutant cells by reciprocal SCF and proteasome affinity purifications (AP) in the absence of 
ATP (Figure 4A, B). We used only rpn11-m1 and not rpn11D122/A for this and other experiments, as 
expression of plasmids and harsh growth conditions led to loss of vitality of the latter. In agreement 
with earlier comparative mass spectrometry analysis, calmodulin-based purification of TAP-Rpt6 
proteasomes revealed a loss of Rpn11 alongside other 19S-lid subunits in rpn11-m1 isolates (Figure 
4A) [43]. Nevertheless, similar to WT, TAP-Rpt6 proteasomes of rpn11-m1 co-precipitated with yCul1 
and even pulled out together with Cdc4, suggesting an interaction between the 19S proteasome and 
an assembled SCFCdc4 complex (Figure 4A,B). Reciprocal affinity purification of SCF through RGS-
8His-yCul1 was pulled out together with HMW Ub conjugates in rpn11-m1 but not in WT. The co-
purification of ubiquitinated proteins with RGS-8His-yCul1 represent CRL-ubiquitinated substrates. 
Unlike the results obtained with rpn11-m1, enrichment of high molecular weight Ub chains in total 
extracts of WT cells pretreated by the proteasome inhibitor MG132 did not elute with the SCF (Figure 
4B). The data in Figure 4 suggest that the observed effects are unlikely to stem from depletion of free 
Ub, as although the treatment with MG132 leads to mono-Ub depletion, it does not affect the RGS-
8His-yCul1–Ub interaction. Our data show that upon Rpn11 malfunction, the 19S proteasome 
interacts with assembled SCF complexes loaded with ubiquitinated substrates. 
 
Figure 4. SCF complexes of rpn11-m1 are loaded with ubiquitinated substrates and co-interact with 
the 19S proteasome. (A) WT and rpn11-m1 mutant cells were transformed with a plasmid encoding to 
Rpt6, amino-terminally tagged by a calmodulin binding peptide and two repeats of protein A (CBP-
A2-Rpt6). Total cell extracts (TCE) of overnight-grown cells were subjected to calmodulin-based 
affinity purification (AP). Co-purification of TAP-Rpt6 with other 19S proteasome subunits (Rpn1, 
Rpn8, Rpn11, Rpn12), SCF subunits (yCul1, Cdc4), and Ub was examined by immunoblotting. (B) 
WT, rpn11-m1, and Δcsn5 were transformed with a plasmid expressing RGS-8HIS-yCul1. Cells were 
grown for 24 hours at 28 °C followed by a treatment of WT culture with 50 µM of the proteasome 
inhibitor MG132 for 4 h. Total cell extracts (TCE) were used for a Histidine-based affinity pulldown 
of the RGS-8HIS-yCul1 with co-purified proteins. Defects in proteasome function (in rpn11-m1 and 
WT treated by MG132) were evaluated by the accumulation of the short-lived protein Cdc4 and Ub 
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conjugates (top and middle). Native cell extracts were used for Ni-NTA (nickel-charged affinity resin) 
based pulldown of RGS-8HIS-yCul1, and co-purification with Ub conjugates was examined by 
immunoblotting (bottom). (C) Overnight diluted culture were grown for an additional 6 h before the 
addition of 20 µM CSN5i-3 to the cells. The accumulation of yCul1R in treated and untreated cells was 
evaluated by immunoblotting in three repeats, followed by quantification of densitometry by 
IMAGEJ, and calculation of the ratio between treated and untreated cells at indicated times (8, 10, or 
24 h). 
Considering that CSN activity occurs only after the dissociation of targets from the SCF [28,63-
65], the accumulation of yCul1R in rpn11 mutants at the post-diauxic phase could be explained by the 
tight attraction between the ubiquitinated targets and the SCF (Figure 4A, B), which prevents CSN 
accessibility. To assess this hypothesis, we first confirmed that the CSN is active at the post-diauxic 
phase by treating Δpdr5 cells lacking the ABC drug transporter Pdr5 with a specific inhibitor of Csn5, 
CSN5i-3 [45], and calculated the ratio of yCul1R in CSN5i-3 treated and untreated cells (Figure 4C; 24 
hours in grey). Nevertheless, unlike the effect on Δpdr5 cells, the inhibitor did not have any effect on 
Δpdr5 cells also carrying the rpn11-m1 mutation, suggesting absence of Cullin deNEDDylation in this 
mutant (Figure 4C, black). The above proposes DUB activity of the 19S-lid as a prerequisite for 
vacating the SCF and enabling CSN activity, hence adding Rpn11 to the SCF pathway. 
A hallmark of csn deletion mutants and of Δrub1 is synthetic sickness or lethality with various 
SCF mutants (i.e., cdc53-1, skp1-12, cdc4-1, and cdc34-2 [25,66]). Similarly, decreased viability of rpn11-
m1–Δcsn or rpn11-m1–Δrub1 double mutants in W303 and BY4741 laboratory strains has been 
measured (Figure 5A, S5). Furthermore, microscopic examination and DAPI staining of double 
mutants revealed swollen cells with cytokinesis defects, including diffused mtDNA morphology, 
suggesting additional mitochondrial defects (Figure 5B). Notably, due to the high rate of reversion in 
rpn11-m1, viability of double mutants was assessed at the first generation of growth from spores 
instead of the commonly used drop assay (Figure 5A,B; S5) [67]. 
 
Figure 5. Rpn11 is a component of the SCF axis. (A) Vitality of double mutants cells was determined 
by the loss of their ability to from colonies upon plating on glucose rich agar plates at a permissive 
temperature. Experiments were done thrice (n = 3) and statistical significance was confirmed (left). 
Vitality of single mutants was determined through a drop assay by plating cultures in serial dilution 
in YPD agar dishes (right). Supplementary Figure 5 (S5) includes complementary data. (B) Tetrads of 
WT, single or double mutant strains, or mutant yeast strains separated into spores and the annotated 
strains grown to the first logarithmic phase in the permissive temperature of 28 °C. Cells were stained 
for nucleic acids by DAPI (4′,6-diamidino-2-phenylindole) and observed by ×63 oil immersion 
objective using a florescence microscope. In the double mutants, an aberrant cell phenotype 
reminiscent of the semi-lethal phenotype can be observed. 
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4. Conclusions 
We described two distinct rpn11 mutants that uniquely accumulate Ub and Rub1 modifiers, 
covalently attached to their substrates and attracted to SCF complexes. Our data suggest that 
malfunctioned Rpn11 DUB activity inhibits Cullin deNEDDylation, probably by preventing the CSN 
from reaching its yCul1R substrate through spatial interference of SCF complexes charged with 
ubiquitinated proteins and co-interacting with the proteasome. Notably, equilibrium bias of Rub1 
and Ub in favor of conjugate formation attached to the SCF could also indicate increased activity of 
their enzymatic cascades, both of which depend on Rbx1 as an E3 ligase [68]. This hypothesis should 
be further investigated in the future. Our data on Rpn11 activity as a prerequisite for CSN activity is 
in agreement with previous studies showing that depletion of ATP inhibits the CSN-mediated 
deNEDDylation reaction rate [69], which possibly indicates inhibition of the 19S ATPases ring and 
translocation of substrates. Direct SCF–proteasome interactions have been reported previously [62], 
raising the possibility that SCF unloads ubiquitinated cargo directly to the 26S proteasome for 
proteolysis. It is still unclear what mediates interaction of SCF complexes with proteasomes and 
whether the interaction is direct. Evidently, this interaction is not through subunits lacking in rpn11-
m1 proteasomes (Figure 4B, [43]), nor through the poly-Ub chain or Rub1 [62]. Clearly, the 
significance of this interaction is that the proteasome acts to determine the recycling and reactivation 
of upstream CRL-ubiquitination enzymes. In summary, by studying the accumulation of yCul1R 
conjugates in rpn11 mutants we were able to distinguish between two molecular mechanisms that 
contribute to Cullin NEDDylation cycles: the previously studied redox homeostasis [41] and 
proteasome capacity (the current study). Apparently, a reducing environment supports Cullin 
NEDDylation, whereas proper proteasome function promotes Cullin deNEDDylation (Figure 6). 
 
Figure 6. Regulation of Cullin modification cycles by the proteasome. Mutants of the 19S-lid subunit 
Rpn11 lead to the finding that catalytically active Rpn11 in proteasomes authorizes Cullin 
deNEDDylation by the CSN. 
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